CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 2 of 48

Rheumatology (Oxford)

Briefs 41–80 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Macrophage activation syndrome in systemic lupus erythematous and Still’s disease: distinct phenotypes shaped by the underlying diseases

    Cohort studyLupus & APS

  2. Rheumatology (Oxford)

    Systemic and local autoantibody responses to extracellular matrix proteins define inflammatory phenotypes across arthropathies

    Cross-sectional studyAcross diseases

  3. Rheumatology (Oxford)

    Acute phase reactants in paediatric chronic nonbacterial osteomyelitis: implications for diagnosis and correlation with disease phenotype

    Cohort studyPediatric

  4. Rheumatology (Oxford)

    Complete and acceptable symptom remission in rheumatoid arthritis: PASS-based thresholds derived from the Okomarigoto Sheet

    Cross-sectional studyRA

  5. Rheumatology (Oxford)

    Therapeutic plasma exchange in paediatric ANCA-associated vasculitis: a multicentre real-world experience

    Cohort studyPediatric

  6. Rheumatology (Oxford)

    Celecoxib plus topical flurbiprofen patch versus celecoxib alone for symptomatic knee OA: a randomized controlled trial

    Randomized controlled trialOsteoarthritis

  7. Rheumatology (Oxford)

    Efficacy and safety of upadacitinib in anti-TNF-refractory intestinal Behçet’s disease: a single-center retrospective study

    Cohort studyVasculitis & PMR

  8. Rheumatology (Oxford)

    Selexipag in SSc-associated pulmonary arterial hypertension: long-term real-world data from a multicentre Italian cohort

    Cohort studySystemic sclerosis

  9. Rheumatology (Oxford)

    Baseline disease activity index and forced vital capacity predict clinically meaningful complications and mortality in systemic sclerosis

    Cohort studySystemic sclerosis

  10. Rheumatology (Oxford)

    Cardiovascular and thromboembolic risk in ANCA-associated vasculitis: a nationwide matched cohort study by disease, sex and familial risk

    Cohort studyVasculitis & PMR

  11. Rheumatology (Oxford)

    Clinical characteristics and long-term outcomes in SLE–myositis overlap syndrome: a controlled retrospective cohort study

    Cohort studyLupus & APS

  12. Rheumatology (Oxford)

    Patterns and changes in lifestyle habits of patients with rheumatoid arthritis during the first three years post-diagnosis

    Cohort studyRA

  13. Rheumatology (Oxford)

    Cross-sectional stroke risk identification in RA: integrating traditional and disease-specific factors

    Cross-sectional studyRA

  14. Rheumatology (Oxford)

    Diagnostic performance of HScore for macrophage activation syndrome complicating Still’s disease in adults: a multicentre case–control study

    Diagnostic or prognostic studyAutoinflammatory & rare

  15. Rheumatology (Oxford)

    DNA hypo-methylation of the TNFA gene predicts response to MTX in RA but not in PsA

    Diagnostic or prognostic studyRA

  16. Rheumatology (Oxford)

    68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren’s disease: a prospective case-control study

    Case-control studySjögren's & overlap

  17. Rheumatology (Oxford)

    Radiomic analysis of high-resolution computed tomography predicts interstitial lung disease progression and mortality in systemic sclerosis

    Cohort studySystemic sclerosis

  18. Rheumatology (Oxford)

    Anti-Ro52 antibodies in idiopathic inflammatory myopathies: clinical significance across myositis-specific antibody–defined subgroups

    Cohort studyMyositis

  19. Rheumatology (Oxford)

    The thrombotic burden of high-risk immune thrombocytopenia patients receiving second-line treatments: a systematic review

    Meta-analysisLupus & APS

  20. Rheumatology (Oxford)

    Real-world experience with obinutuzumab in difficult-to-treat myositis: concise report of a case series

    Cohort studyMyositis

  21. Rheumatology (Oxford)

    Self-efficacy in idiopathic inflammatory myopathies: associated factors, profiles and patient-reported outcomes

    Cross-sectional studyMyositis

  22. Rheumatology (Oxford)

    Whole exome sequencing of paediatric patients with Cogan’s syndrome to identify monogenic mimics

    Cohort studyPediatric

  23. Rheumatology (Oxford)

    Single-cell profiling reveals senescent bone marrow mesenchymal stem cell subpopulations driving pathological ossification in ankylosing spondylitis

    Mechanistic studySpondyloarthritis & PsA

  24. Rheumatology (Oxford)

    TAPE in inflammatory rheumatic monoarthritis: a proof-of-concept study

    Research articleOsteoarthritis

  25. Rheumatology (Oxford)

    Acute parvovirus B19-associated inflammatory musculoskeletal disease: clinical phenotypes and remission trajectories from the GIRRCS network

    Cohort study

  26. Rheumatology (Oxford)

    Fractional exhaled nitric oxide is a non-invasive disease activity marker of IgG4-related disease

    Cross-sectional studyAutoinflammatory & rare

  27. Rheumatology (Oxford)

    Time-varying cardiovascular risk of febuxostat vs. allopurinol in gout: a one-stage meta-analysis

    Meta-analysisGout & crystals

  28. Rheumatology (Oxford)

    Mortality and associated factors of JIA in hospitalized Thai children: a nationwide data analysis 2015–2023

    Cohort studyPediatric

  29. Rheumatology (Oxford)

    Systematic review of fatigue assessment instruments for SLE: psychometric validation with COSMIN 2.0 guidelines

    Meta-analysisLupus & APS

  30. Rheumatology (Oxford)

    Different age, different phenotype: a comparative analysis of juvenile and adult-onset dermatomyositis from a tertiary centre

    Cohort studyMyositis

  31. Rheumatology (Oxford)

    Describing flares: a mixed methods study comparing patient and clinician perspectives in systemic lupus erythematosus and other rheumatic diseases

    Cross-sectional studyLupus & APS

  32. Rheumatology (Oxford)

    Effectiveness of biological disease-modifying antirheumatic drugs in progressive pulmonary fibrosis associated with rheumatoid arthritis

    Cohort studyRA

  33. Rheumatology (Oxford)

    PPI-refractory GERD in SSc is driven by distinct oesophageal and gastric motility abnormalities

    Cohort studySystemic sclerosis

  34. Rheumatology (Oxford)

    Sjögren’s disease patients with no hyposalivation and with short oral dryness complaints contain more T cells in salivary gland parenchyma

    Cross-sectional studySjögren's & overlap

  35. Rheumatology (Oxford)

    Osteoporosis prediction in primary Sjögren’s syndrome: development and external validation of a machine-learning comparison model

    Cohort studySjögren's & overlap

  36. Rheumatology (Oxford)

    Cost-effectiveness of herpes zoster vaccination in patients with rheumatoid arthritis

    Cohort studyRA

  37. Rheumatology (Oxford)

    Canakinumab dosing intervals in pediatric colchicine-resistant FMF: outcomes and predictors of successful extension in a real-world cohort

    Cohort studyPediatric

  38. Rheumatology (Oxford)

    Classification performance of the 2023 ACR/EULAR antiphospholipid syndrome criteria: a systematic review and meta-analysis

    Meta-analysisLupus & APS

  39. Rheumatology (Oxford)

    Clinical characteristics and outcomes of paediatric chronic non-bacterial osteomyelitis: a retrospective cohort study with focus on zoledronic acid

    Cohort studyPediatric

  40. Rheumatology (Oxford)

    Subcutaneous versus intravenous ultra-low-dose rituximab in rheumatoid arthritis: a randomized controlled PK-PD non-inferiority trial

    Randomized controlled trialRA

All 1,905 Briefs in ExploreShowing Briefs 41–80 of 1,905, newest first